PRELEUKEMIA

Clinical trials for PRELEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new PRELEUKEMIA trials appear

Sign up with your email to follow new studies for PRELEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New pill shows promise for Tough-to-Treat leukemia

Disease control Recruiting now

This early-stage trial tests a new daily pill, BH-30236, for adults with acute myeloid leukemia (AML) or a high-risk pre-leukemia condition (MDS) that has returned or not responded to prior treatments. The study will first find the safest dose, then test it alone or with another …

Matched conditions: PRELEUKEMIA

Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control

Last updated May 11, 2026 20:39 UTC

PRELEUKEMIA

Get alerted when new PRELEUKEMIA trials appear

New pill shows promise for Tough-to-Treat leukemia